PA007222.m1: Non-conjugated Recombinant Anti-human CD3e Monoclonal Antibody (Clone: UCHT1), Mouse IgG1 Kappa
Recombinant mouse IgG1 Monoclonal Antibody.
Conjugation: non-conjugated.
Specificity/Sensitivity: The recombinant mouse monoclonal antibody (clone: UCHT1) specifically binds to the human T cell receptor CD3.
Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F).
PA007222.h1Fs: Non-conjugated Recombinant Anti-human CD3e Monoclonal Antibody (Clone: UCHT1), Human IgG1 Fc Silent Kappa
Recombinant human IgG1 Monoclonal Antibody with Fc silent mutation.
Conjugation: non-conjugated.
Specificity/Sensitivity: The recombinant UCHT1 antibody specifically binds to the human T cell receptor CD3.
Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F).
PA007223.h1Fs-b: Biotinylated Recombinant Anti-human CD3e Monoclonal Antibody (Clone: UCHT1), Human IgG1 Fc Silent Kappa
Recombinant human IgG1 monoclonal antibody with site-directed biotinylation through the Avi tag at the C-terminus of the antibody heavy chain.
Conjugation: biotin-conjugated.
Specificity/Sensitivity: The site-directed biotinylated recombinant UCHT1 antibody specifically binds to the human T cell receptor CD3.
Applications: Flow cytometry (FC) with various dye conjugation through streptavidin; conjugation to streptavidin agarose beads or streptavidin magnetic beads.PA007277.m1: In vivo Grade Recombinant Anti-human CD16 Monoclonal Antibody, Mouse IgG1 Kappa (Clone: 3G8)
Recombinant mouse IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: 3G8) specifically binds to human and non-human primate CD16.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the human CD16 protein.C123P: Imdevimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade imdevimab biosimilar specifically binds to the spike protein of SARS-CoV-2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by imdevimab.C101P: Sotrovimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody
Recombinant Human IgG1 Kappa Monoclonal Antibody.
Specificity/Sensitivity: The sotrovimab biosimilar specifically binds to the spike protein of SARS-CoV-2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by sotrovimab.C100P: Casirivimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody
Recombinant Human IgG1 Kappa Monoclonal Antibody.
Specificity/Sensitivity: The casirivimab biosimilar specifically binds to the spike protein of SARS-CoV-2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by casirivimab.BP003053: Recombinant SARS-CoV-2 Nucleocapsid Protein-His-Avi (NP Protein, N Protein)
Source: E.coli.
Purity: > 95% by PAGE under reduced condition.BP003052: Recombinant SARS-CoV-2 Spike RBD-His-Avi
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003062: Recombinant Human ACE2-Fc-Avi Protein (rhACE2-Fc)
Source: mammalian cells.
Activity: Immobilized biotinylated recombinant SARS-CoV-2 Spike S RBD with the His Tag at 1 ug/ml (100 ul/well). Dose response curve for rhACE2-Fc fusion protein with the EC50 of 81 ng/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003059: Recombinant SARS Spike RBD-His-Avi
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.Custom Ilama and alpaca monoclonal antibody development (VHH, sdAb or nanobody) by Ilama or alpaca immunization and phage display screening.
Production of camel, Ilama or alpaca VHH in E.coli or VHH-Fc in HEK 293 cells.
Fast turnaround: 4-6 months once the antigen is available.